Cryofocus Medtech Shanghai Co Ltd (6922)

Currency in HKD
5.49
-0.31(-5.34%)
Closed·
6922 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
6922 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.105.79
52 wk Range
3.2014.02
Key Statistics
Bid/Ask
5.29 / 5.50
Prev. Close
5.8
Open
5.79
Day's Range
5.1-5.79
52 wk Range
3.2-14.02
Volume
67.8K
Average Volume (3m)
87.87K
1-Year Change
-27.41%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6922 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Cryofocus Medtech Shanghai Co Ltd Company Profile

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People’s Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases. Its products include the Bladder Cryoablation System, a cryotherapy device for the treatment of non-muscle-invasive bladder cancer; the Gastric Cryoablation System, a self-developed cryoablation system indicated for performing cryoablation on gastric tumors to treat gastric cancer; the Esophageal Cryospray System, for intermediate to advanced esophagus cancer; the pulmonary nodule localization needle for CT-guided localization of lung nodules; the endoscopic clip for anastomosis for the closure of soft tissue in the digestive tract; the laparoscopic single-port multichannel access platform for laparoscopic surgery; the Atrial Fibrillation Pulsed Field Ablation System, for paroxysmal atrial fibrillation; the Anti-Gastroesophageal Reflux System, for gastroesophageal reflux disease; and other non-cryotherapy products. It also provides wound retractors for small incision surgery and minimally invasive surgery; ureteral dilation balloon catheters for ureteral stricture; laparoscopic biopsy bags for biopsy; and laparoscopic surgical instruments for laparoscopy applications. Cryofocus Medtech (Shanghai) Co., Ltd. was incorporated in 2013 and is based in Shanghai, the People’s Republic of China.

Employees
276
Market
Hong Kong

Compare 6922 to Peers and Sector

Metrics to compare
6922
Peers
Sector
Relationship
P/E Ratio
−15.8x−17.4x−0.5x
PEG Ratio
−0.580.020.00
Price/Book
20.9x2.4x2.6x
Price / LTM Sales
14.1x6.7x3.3x
Upside (Analyst Target)
-−4.2%43.3%
Fair Value Upside
Unlock3.6%6.9%Unlock

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-0.22 / --
Revenue / Forecast
34.06M / --
EPS Revisions
Last 90 days

6922 Income Statement

FAQ

What Stock Exchange Does Cryofocus Medtech Shanghai Trade On?

Cryofocus Medtech Shanghai is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Cryofocus Medtech Shanghai?

The stock symbol for Cryofocus Medtech Shanghai is "6922."

What Is the Cryofocus Medtech Shanghai Market Cap?

As of today, Cryofocus Medtech Shanghai market cap is 1.39B.

What Is Cryofocus Medtech Shanghai's Earnings Per Share (TTM)?

The Cryofocus Medtech Shanghai EPS (TTM) is -0.32.

From a Technical Analysis Perspective, Is 6922 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Cryofocus Medtech Shanghai Stock Split?

Cryofocus Medtech Shanghai has split 0 times.

How Many Employees Does Cryofocus Medtech Shanghai Have?

Cryofocus Medtech Shanghai has 276 employees.

What is the current trading status of Cryofocus Medtech Shanghai (6922)?

As of 11 Aug 2025, Cryofocus Medtech Shanghai (6922) is trading at a price of 5.49, with a previous close of 5.80. The stock has fluctuated within a day range of 5.10 to 5.79, while its 52-week range spans from 3.20 to 14.02.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.